Remote CBT for Insomnia Improves Symptoms During Chemo

Published Date: 02 Sep 2026

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Read Full News

Latest News

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Saturated Fat Tied to Worse Survival After Prostate Cancer

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Medication Self-Injection Embraced by Breast Cancer Patients

Women with breast cancer show interest in self-injecting their medication.

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Latest News

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Women with breast cancer show interest in self-injecting their medication.

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

News All Time

Preschoolers With Cancer Have Poor Motor Skills

Preschool children newly diagnosed with cancer exhibit significant motor impairments, reduced mobility, and weak grip strength at diagnosis, study shows.

Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?

The oral drug naltrexone-bupropion helps some breast cancer survivors lose weight.

Fixed-Duration Combo Shows Promise for Relapsed MCL

Researchers examine the efficacy of fixed-duration mosunetuzumab plus polatuzumab vedotin in patients with heavily pretreated relapsed/refractory mantle cell lymphoma.

US Cancer Trials Heavily Favor Single Drugs Over Care Issues

Industry trials focus on single drugs, while publicly funded trials often look at broader cancer care. It’s a ‘complementary’ approach, but pharma enrolls over 90% of patients.

Ruxolitinib Reduces Acute GVHD in Transplant Patients

A phase 3 trial evaluates a low-dose ruxolitinib-based regimen for graft-vs-host disease prophylaxis among patients undergoing haploidentical hematopoietic stem-cell transplantation.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

novel approach to test the toxicity of cancer drugs.

3.

A protein with new anticancer activity has been identified

4.

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

5.

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

1.

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

2.

Teaching Hematology Through Morphology-Based Learning

3.

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide

4.

Immune Recovery After Intensive Cancer Therapy

5.

Cancer Prehabilitation and Functional Recovery Pathways: An Evidence-Based Review

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

2.

Blood Clotting Disorders Explained

3.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Remote CBT for Insomnia Improves Symptoms During Chemo

Latest News

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

Talc Powder Not Linked to Lung Cancer in Women

Saturated Fat Tied to Worse Survival After Prostate Cancer

Medication Self-Injection Embraced by Breast Cancer Patients

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

Low Awareness of How to Spot Rare Breast Cancer Identified

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Latest News

News All Time

Preschoolers With Cancer Have Poor Motor Skills

Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?

Fixed-Duration Combo Shows Promise for Relapsed MCL

US Cancer Trials Heavily Favor Single Drugs Over Care Issues

Ruxolitinib Reduces Acute GVHD in Transplant Patients

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

How Much of a Cancer Drug Is Too Much?

Belgian Algorithm Reshapes Endometrial Cancer Care

NPM1-Mutated AML: Not All Treatments Are Equal

Transgender Individuals Prefer HPV Self-Swabs

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

FDA Approves Iberdomide Combo for Multiple Myeloma

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Wide Variation Seen in Lung Screening False-Positive Rates

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

AVD Chemo Regimen Shows Promise in Older Patients With HL

Recommended News For You

Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

AI-Driven Biomarker Predicts Prostate Cancer Outcomes